• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[乳腺癌细胞激素受体对无病生存期的意义]

[Significance of hormone receptors of breast cancer cells for the duration of a disease-free interval].

作者信息

Zielinski C C, Kuzmits R, Kubista E, Salzer H, Staffen A, Aiginger P, Spona J

出版信息

Wien Klin Wochenschr. 1985 May 24;97(11):493-7.

PMID:4013343
Abstract

The importance of the presence of hormone receptors of cells derived from breast cancer tissue for the duration of the relapse-free interval was evaluated in 41 patients with stage II breast cancer. After modified radical mastectomy with axillary lymphadenectomy the patients received radiotherapy and adjuvant polychemotherapy and/or hormone therapy. There was no indication of metastases in any patient at the time of operation. There was a significant correlation of the relapse-free interval to tumor size (p less than 0.05), to the number of involved lymph nodes (p less than 0.0005), and also to the presence of the progesterone receptor (PgR), which seemed to play a more important role in this context than the oestrogen receptor (ER) (p less than 0.001). We conclude from this study that the evaluation of the PgR in breast cancer cells is important for the prognosis of the duration of the relapse-free interval.

摘要

对41例II期乳腺癌患者评估了源自乳腺癌组织的细胞中激素受体的存在对无复发生存期的重要性。在改良根治性乳房切除术加腋窝淋巴结清扫术后,患者接受了放疗和辅助多药化疗及/或激素治疗。手术时任何患者均无转移迹象。无复发生存期与肿瘤大小(p<0.05)、受累淋巴结数量(p<0.0005)以及孕激素受体(PgR)的存在均有显著相关性,在这种情况下,PgR似乎比雌激素受体(ER)发挥更重要的作用(p<0.001)。我们从这项研究得出结论,评估乳腺癌细胞中的PgR对无复发生存期的预后很重要。

相似文献

1
[Significance of hormone receptors of breast cancer cells for the duration of a disease-free interval].[乳腺癌细胞激素受体对无病生存期的意义]
Wien Klin Wochenschr. 1985 May 24;97(11):493-7.
2
Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.在接受多柔比星和环磷酰胺序贯紫杉醇辅助化疗的III期乳腺癌患者中,bcl-2表达的预后意义
BMC Cancer. 2007 Apr 12;7:63. doi: 10.1186/1471-2407-7-63.
3
[The importance of steroid receptors for the prognosis and hormone treatment of breast cancer patients: a retrospective study in Southeastern Netherlands].[类固醇受体对乳腺癌患者预后及激素治疗的重要性:荷兰东南部的一项回顾性研究]
Ned Tijdschr Geneeskd. 1998 Aug 1;142(31):1772-8.
4
Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.前列腺特异性抗原(PSA)的表达与复发性乳腺癌对他莫昔芬治疗的不良反应相关。
Br J Cancer. 1999 Feb;79(5-6):888-94. doi: 10.1038/sj.bjc.6690142.
5
Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.bcl-2蛋白的表达可预测可手术的淋巴结阳性乳腺癌辅助治疗的疗效。
Clin Cancer Res. 1995 Feb;1(2):189-98.
6
[Steroid hormone receptors in breast cancer].[乳腺癌中的类固醇激素受体]
Rinsho Byori. 1990 Jan;38(1):26-30.
7
Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.重新评估辅助性乳腺癌试验:通过免疫组化法与提取法评估激素受体状态。
J Natl Cancer Inst. 2006 Nov 1;98(21):1571-81. doi: 10.1093/jnci/djj415.
8
Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.新辅助化疗治疗的Ⅱ/Ⅲ期乳腺癌腋窝淋巴结比率的临床意义
Breast Cancer Res Treat. 2009 Jul;116(1):153-60. doi: 10.1007/s10549-008-0160-9. Epub 2008 Sep 12.
9
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.高危早期乳腺癌中雌激素受体、孕激素受体和微管相关蛋白Tau的基因表达:在希腊合作肿瘤学组试验背景下寻找治疗获益的分子预测指标
Breast Cancer Res Treat. 2009 Jul;116(1):131-43. doi: 10.1007/s10549-008-0144-9. Epub 2008 Jul 31.
10
Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer.在高危乳腺癌患者中,Ⅲ期及雌激素受体阴性与辅助性高剂量治疗后的预后不良相关。
Br J Cancer. 1999 Mar;79(9-10):1500-7. doi: 10.1038/sj.bjc.6690239.

引用本文的文献

1
Androgen receptors, serum androgen levels and survival of breast cancer patients.
Arch Gynecol Obstet. 1990;247(4):203-9. doi: 10.1007/BF02389545.